TITLE:
A Phase 1 Study of S-3304 in Patients With Solid Tumors

CONDITION:
Solid Tumors

INTERVENTION:
S-3304

SUMMARY:

      To determine the maximum tolerated dose and safety profile of S-3304 in patients with biopsy
      accessible cancer who have failed previous therapy or to whom no standard therapies are
      available. To determine the pharmacokinetic profile of S-3304 in this patient population
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 85 Years
Criteria:

        Inclusion criteria:

          -  Biopsy proven diagnosis of solid tumor(s) with biopsy accessible lesion(s)

          -  Must be able to tolerate oral medication Exclusion criteria

          -  Patients with other serious illnesses

          -  Patients who are receiving treatments
      
